As increased vWF levels are a reliable predictor of future venous and arterial thromboembolic events, levels of vWF and NETs could serve as potential biomarkers of risk for COVID-19-related thrombosis and allow for improved monitoring of future thrombotic event risk [28,29]. This evidence concerns the gene VWF and COVID-19.